Cases & Deals

  • Home
  • Practices
  • Abbott purchases option to acquire Cephea Valve Technologies

Share

Abbott purchases option to acquire Cephea Valve Technologies

July 2015

Client(s) Abbott Laboratories

Jones Day advised Abbott Laboratories in the providing of capital and securing of an option to purchase Cephea Valve Technologies, a private company developing a catheter-based mitral valve replacement therapy.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.